Status:
COMPLETED
Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI.
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Human Papilloma Virus
Infertility, Male
Eligibility:
MALE
18-60 years
Brief Summary
This observational study aims to investigate the presence of HPV DNA in semen samples from men undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment. It focuses ...
Detailed Description
Infection with the human papillomavirus (HPV) represents one of the most widespread sexually transmitted diseases, affecting both genders. Over 100 types of HPV can cause infections in the skin or muc...
Eligibility Criteria
Inclusion
- Over the course of one year, the study will include men undergoing infertility treatment with IVF/ICSI and fresh ejaculated sperm at Sahlgrenska University Hospital (SU), Gothenburg, Sweden.
Exclusion
- Men undergoing IVF/ICSI treatments with surgically extracted sperm.
- Men undergoing sperm freezing for fertility preservation purposes or possessing previously frozen sperm.
- Sperm donors.
- Men for whom treatment with preimplantation genetic testing (PGT) or egg donation is planned.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2024
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT06161727
Start Date
January 1 2023
End Date
March 28 2024
Last Update
April 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Sahlgrenska University Hospital
Gothenburg, Sweden, 24